DXRDaxor Corporation

NAS · US · Healthcare · Medical Instruments & Supplies · daxor.com

10.00USD-2.91%Mkt Cap: 58.38M $P/E: 6.103d ago

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap58.38M $

Enterprise Value—

Revenue (TTM)26.69K $

Gross Profit26.69K $

Net Income (TTM)9.17M $

Revenue/Share0.0050 USD

Last Price10.00 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)6.10

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S2251.02

P/B1.13

EPS (TTM)1.64

EPS (Forward)—

52W Range

8.56023% of range14.76

52W High14.76 USD

52W Low8.560 USD

Profitability

Gross Margin100.00%

Oper. Margin-9660.55%

EBITDA Margin0.00%

Profit Margin89.00%

ROE19.98%

ROA19.93%

Growth

Revenue Growth-82.60%

Earnings Growth329.30%

Cash Flow & Leverage

Operating CF570.94K $

CapEx (TTM)—

FCF Margin375.63%

FCF Yield0.17%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.08

Quick Ratio—

Book Value/Sh9.069 USD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield0.52%

Payout Ratio0.00%

Ex-Div DateJan 5, 2018

Pay DateJan 12, 2018

Analyst Consensus

Rating—

Target (Mean)22.50 USD

Upside (mean)+125.0%

Target Range22.00 USD – 23.00 USD

$22.00+125.0% to mean$23.00

# Analysts2

Ownership

Shares Out.5.84M

Float2.51M

Insiders49.46%

Institutions7.02%

Short Interest

Short Ratio0.2d

Short % Float0.01%

Short % Out.0.01%

Shares Short348

Short (prev mo.)1.28K

Technical

SMA 5010.30 (-2.9%)

SMA 20011.41 (-12.4%)

Beta0.27

S&P 52W Chg18.16%

Avg Vol (30d)1.53K

Avg Vol (10d)1.64K

Technical Indicators

RSI (14)44.0

MACD-0.0572

MACD Signal-0.0047

MACD Hist.-0.0525

BB Upper10.97 USD

BB Middle10.46 USD

BB Lower9.940 USD

BB Width9.86%

ATR (14)0.3740 USD

Vol Ratio (20d)1.09x